Cargando…
Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study
Background: Different liquid chromatography tandem mass spectrometry (LC–MS/MS) methods have been published for quantification of monoclonal antibodies (mAbs) in plasma but thus far none allowed the simultaneous quantification of several mAbs, including immune checkpoint inhibitors. We developed and...
Autores principales: | Marin, Clémence, Khoudour, Nihel, Millet, Aurélien, Lebert, Dorothée, Bros, Pauline, Thomas, Fabienne, Ternant, David, Lacarelle, Bruno, Guitton, Jérôme, Ciccolini, Joseph, Blanchet, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401780/ https://www.ncbi.nlm.nih.gov/pubmed/34451893 http://dx.doi.org/10.3390/ph14080796 |
Ejemplares similares
-
Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
por: Millet, Aurélien, et al.
Publicado: (2021) -
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
por: Becher, François, et al.
Publicado: (2017) -
Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa
por: Millet, Aurélien, et al.
Publicado: (2021) -
Development of an LC-MS/MS peptide mapping protocol for the NISTmAb
por: Mouchahoir, Trina, et al.
Publicado: (2018) -
A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal Transplantation
por: Chhun, Stéphanie, et al.
Publicado: (2023)